Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. William Gradishar

Breast Oncology · NU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    DFDr. Daniel Flora

    Dr. Daniel Flora

    Hematology & Oncology · Melanoma Oncology
    St Elizabeth Healthcare
    danielf
    Edgewood, KY, USA

    Research

    Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma

    2026

    Via Clinical Cancer Research

    Research

    T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

    2025

    Via Journal for Immunotherapy of Cancer

    Research

    Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

    2024

    Via Clinical Lung Cancer

    Research

    Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

    2023

    Via JAMA Oncology

    Research

    Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

    2023

    Via BMC Cancer

    Research

    COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

    2023

    Via Translational Oncology

    Research

    Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19

    2023

    Via JAMA Oncology

    Research

    Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

    2023

    Via eLife

    Research

    Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

    2022

    Via JAMA Network Open

    Research

    Social Distancing to Avoid SARS-CoV-2 Infection in Cancer and Noncancer Patients

    2022

    Via Journal of Patient Safety

    Research

    Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

    2021

    Via Annals of Oncology

    Research

    Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

    2021

    Via JAMA Oncology

    Research

    Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

    2020

    Via JNCI Cancer Spectrum

    Research

    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    2020

    Via The Lancet

    Research

    Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

    2018

    Via Cancer Medicine